HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sclerema Neonatorum

A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible.
Networked: 31 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Panniculitis
2. Necrosis
3. Dermatomyositis (Dermatopolymyositis)
4. Thrombotic Microangiopathies
5. Zygomycosis (Phycomycosis)

Experts

1. Estébanez, Andrea: 1 article (11/2020)
2. Folch Briz, Rocío: 1 article (11/2020)
3. García Vázquez, Alejandro: 1 article (11/2020)
4. Gil Viana, Rocío: 1 article (11/2020)
5. Guillen-Climent, Santiago: 1 article (11/2020)
6. María Martín, José: 1 article (11/2020)
7. Pons Benavent, Martí: 1 article (11/2020)
8. Ramón Quiles, María Dolores: 1 article (11/2020)
9. Sáez-Martín, Luis Carlos: 1 article (11/2020)
10. Wick, Mark R: 1 article (05/2017)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Sclerema Neonatorum:
1. SteroidsIBA
2. Anti-Bacterial Agents (Antibiotics)IBA
3. Free RadicalsIBA
4. Adrenocorticotropic Hormone (ACTH)FDA Link
5. CortisoneFDA Link
6. Adrenal Cortex Hormones (Corticosteroids)IBA
7. Cystatin CIBA
8. Palmitic Acid (Hexadecanoic Acid)IBA
9. Intravenous Immunoglobulins (IVIG)FDA Link
10. ZincIBA

Therapies and Procedures

1. Therapeutics
2. Operative Surgical Procedures
3. Injections
4. Blood Transfusion (Blood Transfusions)